In April of 2020, Excel passed FDA inspection of one of its investigational drugs with no deficiencies or citations. ECRD works closely with CROs & IRBs, to support sponsored clinical trials in the field of oncology radiopharmaceuticals. We offer our expertise in conducting clinical research to a variety of academic institutions and pharmaceutical companies. Our team is fully trained regarding rules and regulations of conducting human research, FDA requirements, and IRB compliance. The Excel Clinical Research Department (ECRD) is a dedicated department to assist investigators in their clinical trials. At Excel, you will find areas designed to safely handle and administer radiopharmaceuticals, patient care areas, and physician interpretation resources. All our research staff is GCP Trained and CITI certified consisting of highly trained, board-certified investigators, study coordinators, patient recruiters, and support staff. EDNOC is fully capable of conducting sponsored clinical research trials in the field of diagnostic and therapeutic nuclear medicine. Rodolfo Nuñez, Director of Nuclear Medicine Department at EDNOC.Ībout Excel Diagnostics and Nuclear Oncology Center (EDNOC)ĮDNOC is an outpatient facility offering a full spectrum of diagnostic imaging, nuclear medicine and Radioligand therapies. Excel with its strong infrastructure and knowledge in research and standard of care in therapeutic nuclear medicine is ready to meet these challenges,” said Dr. “We firmly believe that the menu of targeted Radioligand Therapies will increase in the future. Ebrahim Delpassand, Chairman and Medical Director of EDNOC. Our main mission in the last 15 years has been to address unmet needs in the field of Nuclear Oncology,” said Dr. EDNOC continues to be a pioneer in bringing new targeted Radioligand Therapies such as Lu-177 DOTATATE, and Lu-177 PSMA-617 and 225Ac-PSMA I&T to serve our patients in the United States and neighboring countries. “Excel is the first outpatient private facility in the country to receive this honorable designation from SNMMI. HOUSTON, J(GLOBE NEWSWIRE) - Excel Diagnostics and Nuclear Oncology Center (EDNOC), a premier Diagnostic Imaging and Radioligand Therapy center in Houston, Texas announces designation as Radiopharmaceutical Therapy Center of Excellence (RTCOE) by the Society of Nuclear Medicine and Molecular Imaging (SNMMI). J14:44 ET | Source: Excel Diagnostics and Nuclear Oncology Center Excel Nuclear Oncology Center in Houston is designated as Radiopharmaceutical Therapy Center of Excellence by SNMMI
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |